Core activities

Activity 3. Multiple Myeloma (MM)

  • Standardization of the clinical data and biobanking
  • outcome of populations of special interest
  • Evaluation of Minimal Residual Disease (MRD)
  • Analysis of DNA damage response and repair
  • MM induced epigenetic changes


Professor Dr. H. Goldschmidt, Professor Dr. A. Dimitrakopoulou-Strauss (DKFZ) / Professor M.A. Dimopoulos, Ass. Prof. E. Terpos, Ass. Prof. E. Kastritis ( Univ. Athens), Dr. V. Souliotis (NHRF)

Key researchers-clinicians: Coordinators, Dr. C. Sachpekidis (DKFZ)


Other collaborative grants

  • ELMUMY (Elucidation of risk factors and health determinants associated with progression of Monoclonal Gammopathies to Multiple Myeloma), submitted under the Horizon Europe HORIZON-MISS-2021-CANCER-02 call, has been selected for funding by the European Commission, having achieved the highest score of all proposals that were submitted (14.5/15). [Read more]